M S Mayo|D J Buchsbaum - JoVE Visualize

Showing results (71-80 of 132) with videos related to

Pageof 14

Sort By:

Nucleic Acids Research|July 3, 1998

Pausing of reverse transcriptase on retroviral RNA templates is influenced by secondary structures both 5' and 3' of the catalytic siteG P Harrison, M S Mayo, E Hunter, et al.

American Journal of Surgery|March 29, 2000

Local recurrence following breast conservation therapy in African-American women with invasive breast cancerC S Connor, A K Touijer, L Krishnan, et al.

Journal of the American College of Nutrition|October 7, 2000

Homocysteine elevation in sickle cell diseaseE A Lowenthal, M S Mayo, P E Cornwell, et al.

Endocrine-Related Cancer|June 11, 2005

Breast-tissue sampling for risk assessment and preventionC J Fabian, B F Kimler, M S Mayo, et al.

Journal of Clinical Microbiology|July 17, 1998

Application of competitive PCR to cerebrospinal fluid samples from patients with herpes simplex encephalitisR B Domingues, F D Lakeman, M S Mayo, et al.

Blood|July 27, 2000

Molecular modification of a recombinant anti-CD3epsilon-directed immunotoxin by inducing terminal cysteine bridging enhances anti-GVHD efficacy and reduces organ toxicity in a lethal murine modelD A Vallera, D W Kuroki, A Panoskaltsis-Mortari, et al.

Cancer Gene Therapy|August 6, 2005

Combination of cytosine deaminase suicide gene expression with DR5 antibody treatment increases cancer cell cytotoxicityS A Kaliberov, S Chiz, L N Kaliberova, et al.

Gut|January 29, 2008

Genetically designing a more potent antipancreatic cancer agent by simultaneously co-targeting human IL13 and EGF receptors in a mouse xenograft modelD A Vallera, B J Stish, Y Shu, et al.

International Journal of Radiation Oncology, Biology, Physics|March 15, 1993

Comparison of 131I- and 90Y-labeled monoclonal antibody 17-1A for treatment of human colon cancer xenograftsD J Buchsbaum, T S Lawrence, P L Roberson, et al.

Biotechniques|May 1, 1990

A new conjugating agent for radioiodination of proteins: low in vivo deiodination of a radiolabeled antibody in a tumor modelP C Srivastava, D J Buchsbaum, J F Allred, et al.

Pageof 14

Showing results (71-80 of 132) with videos related to

Sort By:

Pageof 14

Nucleic Acids Research|July 3, 1998

Pausing of reverse transcriptase on retroviral RNA templates is influenced by secondary structures both 5' and 3' of the catalytic siteG P Harrison, M S Mayo, E Hunter, et al.

American Journal of Surgery|March 29, 2000

Local recurrence following breast conservation therapy in African-American women with invasive breast cancerC S Connor, A K Touijer, L Krishnan, et al.

Journal of the American College of Nutrition|October 7, 2000

Homocysteine elevation in sickle cell diseaseE A Lowenthal, M S Mayo, P E Cornwell, et al.

Endocrine-Related Cancer|June 11, 2005

Breast-tissue sampling for risk assessment and preventionC J Fabian, B F Kimler, M S Mayo, et al.

Journal of Clinical Microbiology|July 17, 1998

Application of competitive PCR to cerebrospinal fluid samples from patients with herpes simplex encephalitisR B Domingues, F D Lakeman, M S Mayo, et al.

Blood|July 27, 2000

Molecular modification of a recombinant anti-CD3epsilon-directed immunotoxin by inducing terminal cysteine bridging enhances anti-GVHD efficacy and reduces organ toxicity in a lethal murine modelD A Vallera, D W Kuroki, A Panoskaltsis-Mortari, et al.

Cancer Gene Therapy|August 6, 2005

Combination of cytosine deaminase suicide gene expression with DR5 antibody treatment increases cancer cell cytotoxicityS A Kaliberov, S Chiz, L N Kaliberova, et al.

Gut|January 29, 2008

Genetically designing a more potent antipancreatic cancer agent by simultaneously co-targeting human IL13 and EGF receptors in a mouse xenograft modelD A Vallera, B J Stish, Y Shu, et al.

International Journal of Radiation Oncology, Biology, Physics|March 15, 1993

Comparison of 131I- and 90Y-labeled monoclonal antibody 17-1A for treatment of human colon cancer xenograftsD J Buchsbaum, T S Lawrence, P L Roberson, et al.

Biotechniques|May 1, 1990

A new conjugating agent for radioiodination of proteins: low in vivo deiodination of a radiolabeled antibody in a tumor modelP C Srivastava, D J Buchsbaum, J F Allred, et al.

Pageof 14